TABLE 3.
Cellular maker and/or cell type | Sampling date (no. of wks p.i.)a | Nerve bundle MOCb | Neuronal soma (ganglion) MOCb | Cellular structure |
---|---|---|---|---|
βIII-Tubulin | 8–9 | NS | ND | Microtubule network in axons |
Synaptophysin | 8–9 | NS | ND | SVPs in axonsd |
LAMP-1 | 8–9 | ** | * | Late endosomes, lysosomes |
13 | *** | *** | ||
dCAD cellsc | *** | *** | ||
Cathepsin D | 13 | * | * | Mature lysosomes |
Myelin P2 | 8–9 | * | ND | Myelin |
p.i., postinfection.
A t test (unpaired, two-tailed) comparing the Manders' overlap coefficient (MOC) of PrPSc and cellular markers in mock-infected and HY TME-infected tongue or between mock-infected and 22L scrapie-infected differentiated CAD cells in vitro was performed. ND, not done; NS, not statistically significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001.
dCAD, CAD cell line was switched to serum-free medium to induce differentiation, which results in cessation of cell division, extension of neurites, and formation of phase-bright cell bodies. For dCAD cells, LSCM analysis was performed in neurites and cell bodies and could be morphologically related to axons in nerve bundles and somata of ganglia cells, respectively, in the tongue.
SVPs, synaptic vesicle precursors.